LigaSure™ technology has been used in more than 4 million procedures worldwide.

There are well over 200 published peer-reviewed studies on LigaSure™ technology.

TissueFect™ sensing technology monitors changes in tissue impedance 3,333 times a second, and adjusts energy output accordingly to deliver the appropriate amount of energy for the desired tissue effect.

Valleylab™ mode is responsive energy that helps surgeons manage the tissue effect of surgical devices.

LigaSure™ technology can fuse vessels, including pulmonary vasculature*, up to and including 7 mm, lymphatics and tissue bundles with an average seal cycle of two to four seconds* (*when used with the ForceTriad™ energy platform).

Clinical Specialties

LigaSure™ technology has been used in more than 4 million procedures in a range of surgical specialties, including colorectal, gynecology, urologic and general surgery. More than 200 published peer-reviewed studies support the safety and efficacy of LigaSure™ technology, and the benefits it provides to clinical practice and procedural outcomes.